Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
NCT ID: NCT06232590
Last Updated: 2025-02-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-02-23
2024-07-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
NCT05166902
Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses
NCT05805059
Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT06469242
Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT05933772
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05338333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Lens, then Test Lens
Participants wore Control Lens for 1 month, then the Test Lens for 1 month
Control Lens (comfilcon A)
Multifocal monthly replacement contact lens for 1 month
Test Lens (lehfilcon A)
Multifocal monthly replacement contact lens for 1 month
Test Lens, then Control Lens
Participants wore the Test Lens for 1 month, then the Control Lens for 1 month
Control Lens (comfilcon A)
Multifocal monthly replacement contact lens for 1 month
Test Lens (lehfilcon A)
Multifocal monthly replacement contact lens for 1 month
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control Lens (comfilcon A)
Multifocal monthly replacement contact lens for 1 month
Test Lens (lehfilcon A)
Multifocal monthly replacement contact lens for 1 month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Had read and signed an information consent letter;
3. Self-reported having had a full eye examination in the previous two years;
4. Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
5. Were willing and able to follow instructions and maintain the appointment schedule;
6. Habitually wore spherical multifocal soft contact lenses, for the past 3 months minimum:
* Maximum of 4 participants (out of 12) per site could be habitual wearers of daily disposable lenses,
* Maximum of 4 participants (out of 12) per site could be habitual wearers of Biofinity Multifocal,
* Maximum of 4 participants (out of 12) per site could be habitual wearers of either TOTAL30 Multifocal or AirOptix plus HydraGlyde Multifocal
7. Had refractive astigmatism no higher than -0.75DC;
8. Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D;
9. Could be fit and achieve binocular distance vision of at least 20/30 Snellen which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design).
Exclusion Criteria
2. Had any known active ocular disease and/or infection that contraindicated contact lens wear;
3. Had a systemic or ocular condition that in the opinion of the investigator may have affected a study outcome variable;
4. Were using any systemic or topical medications that in the opinion of the investigator may have affect contact lens wear or a study outcome variable;
5. Had known sensitivity to the diagnostic sodium fluorescein used in the study;
6. Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
7. Had undergone refractive error surgery or intraocular surgery.
42 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Ocular Research & Education, Canada
OTHER
CooperVision International Limited (CVIL)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Sacco
Role: PRINCIPAL_INVESTIGATOR
Sacco Eye Group
David Wilkinson
Role: PRINCIPAL_INVESTIGATOR
Spadina Optometry
Katherine Bickle
Role: PRINCIPAL_INVESTIGATOR
ProCare Vision Center
Dustin Gardner
Role: PRINCIPAL_INVESTIGATOR
New Bremen EyeCare
Gina Wesley
Role: PRINCIPAL_INVESTIGATOR
Complete Eye Care of Medina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complete Eye Care of Medina
Medina, Minnesota, United States
Sacco Eye Group
Vestal, New York, United States
ProCare Vision Center
Granville, Ohio, United States
New Bremen EyeCare
New Bremen, Ohio, United States
Spadina Optometry
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.